PT-141 Therapy in Miami, FL

What Is PT-141?

PT-141, also known as bremelanotide, is a synthetic peptide that increases sexual desire and arousal through a mechanism found in no other sexual health medication. While treatments like Viagra and Cialis work on blood flow, and testosterone therapy works on hormonal levels, PT-141 works directly in the central nervous system — activating melanocortin receptors in the brain that regulate sexual desire, arousal, and motivation.

PT-141 is FDA-approved under the brand name Vyleesi for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women, making it one of the only FDA-approved treatments specifically targeting low sexual desire. At Rewind Anti-Aging of Miami, we also prescribe PT-141 for men whose sexual dysfunction includes a significant desire or arousal component, and for postmenopausal women experiencing desire-related sexual difficulties.

How PT-141 Works: Melanocortin Receptors and Sexual Desire

Every other sexual health treatment on the market targets the peripheral mechanisms of sexual function — blood flow to the genitals, hormone levels in the blood, or nerve sensitivity in genital tissue. PT-141 is fundamentally different because it targets the central mechanism — the brain itself.

PT-141 activates melanocortin-4 receptors (MC4R) in the hypothalamus and other brain regions involved in sexual behavior. The melanocortin system is a network of neuropeptide pathways that regulate a range of functions including appetite, energy balance, and — critically — sexual desire and arousal. When MC4R receptors are activated, they trigger downstream signaling cascades that increase:

• Sexual desire — the subjective feeling of wanting to be sexually active
• Sexual arousal — the mental and physical state of readiness for sexual activity
• Genital blood flow — as a downstream effect of central arousal signaling, PT-141 also promotes genital engorgement in both men and women

This distinction is clinically important. Many people with sexual dysfunction — both men and women — experience reduced desire, not just reduced physical capability. A man may be able to achieve an erection with Viagra but feel no genuine desire for intimacy. A woman may have normal hormone levels and healthy genital tissue but experience no motivation for sexual activity. PT-141 addresses this specific gap in ways that no other treatment can.

Who PT-141 Is For

Women with HSDD

PT-141's FDA approval was specifically for premenopausal women with Hypoactive Sexual Desire Disorder — a persistent, distressing lack of sexual desire. In clinical trials, women receiving PT-141 reported significant increases in sexual desire and significant decreases in distress related to their low libido compared to placebo. We also prescribe PT-141 off-label for postmenopausal women experiencing desire-related dysfunction, often as part of a broader treatment plan that includes hormone optimization and topical arousal therapies. Learn more on our female sexual health page.

Men with Desire-Related ED

Not all erectile dysfunction is a plumbing problem. Many men — particularly those dealing with stress, performance anxiety, relationship issues, depression, or SSRI side effects — experience ED that is rooted in reduced desire rather than reduced blood flow. For these men, Viagra or Cialis may produce an erection but does not restore the genuine feeling of wanting to be intimate. PT-141 addresses this desire component directly. It is particularly effective when combined with a PDE5 inhibitor for men who benefit from both neurological desire enhancement and vascular support.

Men and Women on SSRIs

SSRI antidepressants (sertraline, paroxetine, fluoxetine, escitalopram) are well known for causing sexual side effects — including dramatically reduced desire, difficulty with arousal, and anorgasmia. Because PT-141 works through a different pathway (melanocortin receptors rather than serotonin receptors), it can help counteract SSRI-induced sexual dysfunction without interfering with the antidepressant effect.

How PT-141 Is Administered

PT-141 is administered as a subcutaneous injection — a small injection into the fat layer just beneath the skin, similar to an insulin injection. The process is straightforward:

• Timing: Inject approximately 45 to 60 minutes before anticipated sexual activity.
• Injection site: The abdomen or thigh are the most common sites. We teach you the proper technique during your consultation.
• Duration of effect: Effects typically last several hours after injection, providing a comfortable window for intimacy.
• Frequency limits: PT-141 should not be used more than once in a 24-hour period and no more than 8 doses per month.

Side Effects of PT-141

PT-141 has a well-characterized side effect profile from its clinical trials:

• Nausea — the most commonly reported side effect, occurring in approximately 40% of patients in clinical trials. Nausea is usually mild to moderate, peaks within the first hour after injection, and typically diminishes significantly with repeated use as the body adjusts.
• Flushing — warmth and redness in the face, neck, or chest. Generally mild and temporary.
• Headache — reported by some patients, usually mild and short-lived.
• Injection site reactions — mild redness or irritation at the injection site, resolving quickly.
• Transient blood pressure increase — PT-141 can cause a temporary elevation in blood pressure. Patients with uncontrolled hypertension or significant cardiovascular disease should discuss this with their provider before use.

To minimize nausea, we often recommend starting with a lower dose and titrating up, and suggest taking PT-141 with a light snack rather than on a completely empty stomach. Most patients find that nausea significantly decreases or resolves entirely after the first few uses.

Why PT-141 Matters in Sexual Health Treatment

For decades, sexual health treatment has focused almost exclusively on the physical mechanics — blood flow, hormones, and tissue health. PT-141 represents a paradigm shift: the recognition that desire is a neurological event, and that treating desire requires targeting the brain, not just the body.

At Rewind Anti-Aging of Miami, PT-141 is one tool in a comprehensive sexual health toolkit that includes PDE5 inhibitors, injectable therapy, testosterone optimization, and topical arousal treatments. By combining the right treatments for each patient's unique situation, we address sexual function from every relevant angle.